Download PDF
Semin Reprod Med 2014; 32(04): 313-318
DOI: 10.1055/s-0034-1375184
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Medical Management of Male Infertility in the Absence of a Specific Etiology

Ahmet Gudeloglu
1   The PUR Clinic, Personalized Urology and Robotics, Ankara, Turkey
,
Jamin V. Brahmbhatt
2   The PUR Clinic, Personalized Urology and Robotics, Clermont, Florida
3   South Lake Hospital, Clermont, Florida
,
Sijo J. Parekattil
2   The PUR Clinic, Personalized Urology and Robotics, Clermont, Florida
3   South Lake Hospital, Clermont, Florida
› Author Affiliations
Further Information

Publication History

Publication Date:
11 June 2014 (online)

    Permissions and Reprints

Abstract

Idiopathic male infertility can be diagnosis in approximately one-third of infertile males. The empirical medical treatment with or without assisted reproductive techniques appears common in male infertility practice. This type of management can be classified as hormonal treatment including gonadotropins, antiestrogens, and aromatase inhibitors and support with antioxidant supplements such as carnitine, lycopene, glutathione, and vitamin E. This review investigates the evidence of commonly used empirical medical management of male infertility when there is no demonstrable diagnosis.

Keywords

idiopathic male infertility - empirical medical treatment - gonadotropins - antiestrogens - aromatase inhibitors - clomiphene - anastrozole - antioxidants - carnitine - lycopene
 

  • References

  • 1 Jungwirth A, Giwercman A, Tournaye H , et al; European Association of Urology Working Group on Male Infertility. European Association of Urology guidelines on Male Infertility: the 2012 update. Eur Urol 2012; 62 (2) 324-332
    CrossrefPubMedGoogle Scholar
  • 2 Hamada A, Esteves SC, Nizza M, Agarwal A. Unexplained male infertility: diagnosis and management. Int Braz J Urol 2012; 38 (5) 576-594
    CrossrefPubMedGoogle Scholar
  • 3 Schiff JD, Ramírez ML, Bar-Chama N. Medical and surgical management male infertility. Endocrinol Metab Clin North Am 2007; 36 (2) 313-331
    CrossrefPubMedGoogle Scholar
  • 4 Kumar R, Gautam G, Gupta NP. Drug therapy for idiopathic male infertility: rationale versus evidence. J Urol 2006; 176 (4, Pt 1) 1307-1312
    CrossrefPubMedGoogle Scholar
  • 5 Ko EY, Siddiqi K, Brannigan RE, Sabanegh Jr ES. Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association. J Urol 2012; 187 (3) 973-978
    CrossrefPubMedGoogle Scholar
  • 6 Ruwanpura SM, McLachlan RI, Meachem SJ. Hormonal regulation of male germ cell development. J Endocrinol 2010; 205 (2) 117-131
    CrossrefPubMedGoogle Scholar
  • 7 Jungck EC, Roy S, Greenblatt RB, Mahesh VB. Effect of clomiphene citrate on spermatogenesis in the human. a preliminary report. Fertil Steril 1964; 15: 40-43
    PubMedGoogle Scholar
  • 8 Willets AE, Corbo JM, Brown JN. Clomiphene for the treatment of male infertility. Reprod Sci 2013; 20 (7) 739-744
    CrossrefPubMedGoogle Scholar
  • 9 Wang C, Chan CW, Wong KK, Yeung KK. Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxifylline, and testosterone rebound therapy for the treatment of idiopathic oligospermia. Fertil Steril 1983; 40 (3) 358-365
    PubMedGoogle Scholar
  • 10 Foss GL, Tindall VR, Birkett JP. The treatment of subfertile men with clomiphene citrate. J Reprod Fertil 1973; 32 (1) 167-170
    CrossrefPubMedGoogle Scholar
  • 11 World Health Organization. A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertility. Int J Androl 1992; 15 (4) 299-307
    CrossrefPubMedGoogle Scholar
  • 12 Vandekerckhove P, Lilford R, Vail A, Hughes E. Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev 2000; (2) CD000151
    PubMedGoogle Scholar
  • 13 Patankar SS, Kaore SB, Sawane MV, Mishra NV, Deshkar AM. Effect of clomiphene citrate on sperm density in male partners of infertile couples. Indian J Physiol Pharmacol 2007; 51 (2) 195-198
    PubMedGoogle Scholar
  • 14 Ghanem H, Shaeer O, El-Segini A. Combination clomiphene citrate and antioxidant therapy for idiopathic male infertility: a randomized controlled trial. Fertil Steril 2010; 93 (7) 2232-2235
    CrossrefPubMedGoogle Scholar
  • 15 Moradi M, Moradi A, Alemi M , et al. Safety and efficacy of clomiphene citrate and L-carnitine in idiopathic male infertility: a comparative study. Urol J 2010; 7 (3) 188-193
    PubMedGoogle Scholar
  • 16 Kotoulas IG, Cardamakis E, Michopoulos J, Mitropoulos D, Dounis A. Tamoxifen treatment in male infertility. I. Effect on spermatozoa. Fertil Steril 1994; 61 (5) 911-914
    PubMedGoogle Scholar
  • 17 Kadioglu TC, Köksal IT, Tunç M, Nane I, Tellaloglu S. Treatment of idiopathic and postvaricocelectomy oligozoospermia with oral tamoxifen citrate. BJU Int 1999; 83 (6) 646-648
    PubMedGoogle Scholar
  • 18 Miyagawa Y, Tsujimura A, Matsumiya K , et al. Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study. J Urol 2005; 173 (6) 2072-2075
    CrossrefPubMedGoogle Scholar
  • 19 Ishikawa T, Ooba T, Kondo Y, Yamaguchi K, Fujisawa M. Assessment of gonadotropin therapy in male hypogonadotropic hypogonadism. Fertil Steril 2007; 88 (6) 1697-1699
    CrossrefPubMedGoogle Scholar
  • 20 Warne DW, Decosterd G, Okada H, Yano Y, Koide N, Howles CM. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertil Steril 2009; 92 (2) 594-604
    CrossrefPubMedGoogle Scholar
  • 21 Homonnai ZT, Peled M, Paz GF. Changes in semen quality and fertility in response to endocrine treatment of subfertile men. Gynecol Obstet Invest 1978; 9 (5) 244-255
    CrossrefPubMedGoogle Scholar
  • 22 Chehval MJ, Mehan DJ. Chorionic gonadotropins in the treatment of the subfertile male. Fertil Steril 1979; 31 (6) 666-668
    PubMedGoogle Scholar
  • 23 Attia AM, Al-Inany HG, Proctor ML. Gonadotrophins for idiopathic male factor subfertility. Cochrane Database Syst Rev 2006; (1) CD005071
    PubMedGoogle Scholar
  • 24 Valenti D, La Vignera S, Condorelli RA , et al. Follicle-stimulating hormone treatment in normogonadotropic infertile men. Nat Rev Urol 2013; 10 (1) 55-62
    PubMedGoogle Scholar
  • 25 Schlegel PN. Aromatase inhibitors for male infertility. Fertil Steril 2012; 98 (6) 1359-1362
    CrossrefPubMedGoogle Scholar
  • 26 Clark RV, Sherins RJ. Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover. J Androl 1989; 10 (3) 240-247
    PubMedGoogle Scholar
  • 27 Cavallini G, Beretta G, Biagiotti G. Preliminary study of letrozole use for improving spermatogenesis in non-obstructive azoospermia patients with normal serum FSH. Asian J Androl 2011; 13 (6) 895-897
    CrossrefPubMedGoogle Scholar
  • 28 Kefer JC, Agarwal A, Sabanegh E. Role of antioxidants in the treatment of male infertility. Int J Urol 2009; 16 (5) 449-457
    CrossrefPubMedGoogle Scholar
  • 29 Aitken RJ, Clarkson JS, Fishel S. Generation of reactive oxygen species, lipid peroxidation, and human sperm function. Biol Reprod 1989; 41 (1) 183-197
    CrossrefPubMedGoogle Scholar
  • 30 Henkel R, Kierspel E, Stalf T , et al. Effect of reactive oxygen species produced by spermatozoa and leukocytes on sperm functions in non-leukocytospermic patients. Fertil Steril 2005; 83 (3) 635-642
    CrossrefPubMedGoogle Scholar
  • 31 Agarwal A, Saleh RA, Bedaiwy MA. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril 2003; 79 (4) 829-843
    CrossrefPubMedGoogle Scholar
  • 32 Ryan TC, Weil GJ, Newburger PE, Haugland R, Simons ER. Measurement of superoxide release in the phagovacuoles of immune complex-stimulated human neutrophils. J Immunol Methods 1990; 130 (2) 223-233
    CrossrefPubMedGoogle Scholar
  • 33 Kao SH, Chao HT, Chen HW, Hwang TI, Liao TL, Wei YH. Increase of oxidative stress in human sperm with lower motility. Fertil Steril 2008; 89 (5) 1183-1190
    CrossrefPubMedGoogle Scholar
  • 34 de Lamirande E, Lamothe G. Reactive oxygen-induced reactive oxygen formation during human sperm capacitation. Free Radic Biol Med 2009; 46 (4) 502-510
    CrossrefPubMedGoogle Scholar
  • 35 Ross C, Morriss A, Khairy M , et al. A systematic review of the effect of oral antioxidants on male infertility. Reprod Biomed Online 2010; 20 (6) 711-723
    CrossrefPubMedGoogle Scholar
  • 36 Tremellen K. Oxidative stress and male infertility—a clinical perspective. Hum Reprod Update 2008; 14 (3) 243-258
    CrossrefPubMedGoogle Scholar
  • 37 Young SS, Eskenazi B, Marchetti FM, Block G, Wyrobek AJ. The association of folate, zinc and antioxidant intake with sperm aneuploidy in healthy non-smoking men. Hum Reprod 2008; 23 (5) 1014-1022
    CrossrefPubMedGoogle Scholar
  • 38 Mellinger RC, Thompson RJ. The effect of clomiphene citrate in male infertility. Fertil Steril 1966; 17 (1) 94-103
    PubMedGoogle Scholar
  • 39 Reuter SE, Evans AM. Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects. Clin Pharmacokinet 2012; 51 (9) 553-572
    CrossrefPubMedGoogle Scholar
  • 40 Palmero S, Bottazzi C, Costa M, Leone M, Fugassa E. Metabolic effects of L-carnitine on prepubertal rat Sertoli cells. Horm Metab Res 2000; 32 (3) 87-90
    Article in Thieme ConnectPubMedGoogle Scholar
  • 41 Casillas ER, Villalobos P, Gonzales R. Distribution of carnitine and acylcarnitine in the hamster epididymis and in epididymal spermatozoa during maturation. J Reprod Fertil 1984; 72 (1) 197-201
    CrossrefPubMedGoogle Scholar
  • 42 Matalliotakis I, Koumantaki Y, Evageliou A, Matalliotakis G, Goumenou A, Koumantakis E. L-carnitine levels in the seminal plasma of fertile and infertile men: correlation with sperm quality. Int J Fertil Womens Med 2000; 45 (3) 236-240
    PubMedGoogle Scholar
  • 43 Arduini A. Carnitine and its acyl esters as secondary antioxidants?. Am Heart J 1992; 123 (6) 1726-1727
    PubMedGoogle Scholar
  • 44 Menchini-Fabris GF, Canale D, Izzo PL, Olivieri L, Bartelloni M. Free L-carnitine in human semen: its variability in different andrologic pathologies. Fertil Steril 1984; 42 (2) 263-267
    PubMedGoogle Scholar
  • 45 Zöpfgen A, Priem F, Sudhoff F , et al. Relationship between semen quality and the seminal plasma components carnitine, alpha-glucosidase, fructose, citrate and granulocyte elastase in infertile men compared with a normal population. Hum Reprod 2000; 15 (4) 840-845
    CrossrefPubMedGoogle Scholar
  • 46 Kohengkul S, Tanphaichitr V, Muangmun V, Tanphaichitr N. Levels of L-carnitine and L-O-acetylcarnitine in normal and infertile human semen: a lower level of L-O-acetylcarnitine in infertile semen. Fertil Steril 1977; 28 (12) 1333-1336
    PubMedGoogle Scholar
  • 47 Lenzi A, Sgrò P, Salacone P , et al. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril 2004; 81 (6) 1578-1584
    CrossrefPubMedGoogle Scholar
  • 48 Sigman M, Glass S, Campagnone J, Pryor JL. Carnitine for the treatment of idiopathic asthenospermia: a randomized, double-blind, placebo-controlled trial. Fertil Steril 2006; 85 (5) 1409-1414
    CrossrefPubMedGoogle Scholar
  • 49 Cavallini G, Ferraretti AP, Gianaroli L, Biagiotti G, Vitali G. Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia. J Androl 2004; 25 (5) 761-770 , discussion 771–772
    PubMedGoogle Scholar
  • 50 Balercia G, Regoli F, Armeni T, Koverech A, Mantero F, Boscaro M. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. Fertil Steril 2005; 84 (3) 662-671
    CrossrefPubMedGoogle Scholar
  • 51 Cavallini G, Magli MC, Crippa A, Ferraretti AP, Gianaroli L. Reduction in sperm aneuploidy levels in severe oligoasthenoteratospermic patients after medical therapy: a preliminary report. Asian J Androl 2012; 14 (4) 591-598
    CrossrefPubMedGoogle Scholar
  • 52 Najm W, Lie D. Dietary supplements commonly used for prevention. Prim Care 2008; 35 (4) 749-767
    CrossrefPubMedGoogle Scholar
  • 53 Magri V, Trinchieri A, Perletti G, Marras E. Activity of Serenoa repens, lycopene and selenium on prostatic disease: evidences and hypotheses. Arch Ital Urol Androl 2008; 80 (2) 65-78
    PubMedGoogle Scholar
  • 54 Hwang ES, Bowen PE. Effects of lycopene and tomato paste extracts on DNA and lipid oxidation in LNCaP human prostate cancer cells. Biofactors 2005; 23 (2) 97-105
    CrossrefPubMedGoogle Scholar
  • 55 Mendiola J, Torres-Cantero AM, Vioque J , et al. A low intake of antioxidant nutrients is associated with poor semen quality in patients attending fertility clinics. Fertil Steril 2010; 93 (4) 1128-1133
    CrossrefPubMedGoogle Scholar
  • 56 Gupta NP, Kumar R. Lycopene therapy in idiopathic male infertility—a preliminary report. Int Urol Nephrol 2002; 34 (3) 369-372
    CrossrefPubMedGoogle Scholar
  • 57 Goyal A, Chopra M, Lwaleed BA, Birch B, Cooper AJ. The effects of dietary lycopene supplementation on human seminal plasma. BJU Int 2007; 99 (6) 1456-1460
    CrossrefPubMedGoogle Scholar
  • 58 Meister A, Anderson ME. Glutathione. Annu Rev Biochem 1983; 52: 711-760
    CrossrefPubMedGoogle Scholar
  • 59 Lenzi A, Lombardo F, Gandini L, Culasso F, Dondero F. Glutathione therapy for male infertility. Arch Androl 1992; 29 (1) 65-68
    CrossrefPubMedGoogle Scholar
  • 60 Lenzi A, Picardo M, Gandini L , et al. Glutathione treatment of dyspermia: effect on the lipoperoxidation process. Hum Reprod 1994; 9 (11) 2044-2050
    PubMedGoogle Scholar
  • 61 Meybodi AM, Mozdarani H, Moradi ShZ, Akhoond MR. Importance of sperm gluthatione treatment in ART. J Assist Reprod Genet 2012; 29 (7) 625-630
    CrossrefPubMedGoogle Scholar
  • 62 Agarwal A, Sekhon LH. The role of antioxidant therapy in the treatment of male infertility. Hum Fertil (Camb) 2010; 13 (4) 217-225
    CrossrefPubMedGoogle Scholar
  • 63 Kessopoulou E, Powers HJ, Sharma KK , et al. A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril 1995; 64 (4) 825-831
    PubMedGoogle Scholar
  • 64 Suleiman SA, Ali ME, Zaki ZM, el-Malik EM, Nasr MA. Lipid peroxidation and human sperm motility: protective role of vitamin E. J Androl 1996; 17 (5) 530-537
    PubMedGoogle Scholar
  • 65 Keskes-Ammar L, Feki-Chakroun N, Rebai T , et al. Sperm oxidative stress and the effect of an oral vitamin E and selenium supplement on semen quality in infertile men. Arch Androl 2003; 49 (2) 83-94
    PubMedGoogle Scholar
  • 66 Moslemi MK, Tavanbakhsh S. Selenium-vitamin E supplementation in infertile men: effects on semen parameters and pregnancy rate. Int J Gen Med 2011; 4: 99-104
    PubMedGoogle Scholar